IMP: BOD resolution dated February 23, 2024

BOD resolution dated February 23, 2024 of Imexpharm Corporation as follows:

HOSE

>   DHA: Decision on sanctioning of administrative violations (27/02/2024)

>   TNW: Annual Corporate Governance Report 2023 (27/02/2024)

>   TOS: Board Resolution (27/02/2024)

>   TID: Board Resolution (27/02/2024)

>   SII: Annual Corporate Governance Report 2023 (27/02/2024)

>   SQC: Annual Corporate Governance Report 2023 (27/02/2024)

>   SCO: Board Resolution (27/02/2024)

>   SGS: Annual Corporate Governance Report 2023 (27/02/2024)

>   QNW: Annual Corporate Governance Report 2023 (27/02/2024)

>   QPH: Annual Corporate Governance Report 2023 (27/02/2024)